Related Experiment Videos
[Subglottic carcinoma].
Gideon Bahar1, Ben I Nageris, Tomas Spitzer
1Department of Otorhinolaryngology, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel.
Harefuah
|November 8, 2002
Summary
Subglottic cancers, rare but aggressive, often arise from glottic cancer extension. Early diagnosis of these rare laryngeal cancers is crucial, typically requiring direct laryngoscopy and advanced imaging.
Area of Science:
- Otolaryngology
- Oncology
Background:
- Subglottic malignancies are rare, accounting for approximately 1% of all laryngeal cancers.
- Most subglottic cancers are squamous cell carcinomas, with many originating from glottic cancer extension.
Purpose of the Study:
- To define the subglottic region and review the pathophysiology and behavior of cancers in this location.
- To present the experience in diagnosing and treating four cases of subglottic cancer.
Main Methods:
- Review of definitions for the subglottic region.
- Summary of cancer pathophysiology and behavior.
- Case series of four patients diagnosed and treated between 1995-2000.
- Literature review.
Main Results:
- Subglottic cancer incidence is low; often secondary to glottic cancer.
- Tumor spread involves paraglottic, pretracheal (delphian), and jugular lymph nodes.
- Delayed diagnosis is common due to asymptomatic early stages and hidden location.
- Presenting symptoms include dyspnea and stridor.
- Direct laryngoscopy, CT, and MRI are vital for detection.
- Radical therapy, including total laryngectomy and radiation, is typically indicated.
Conclusions:
- Subglottic cancer requires a high index of suspicion for timely diagnosis.
- Multimodal imaging and direct laryngoscopy are essential for accurate staging and treatment planning.
- Radical surgical and radiotherapeutic approaches are standard for managing subglottic malignancies.